# Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face

> **NCT02723721** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 20 (actual)

## Conditions studied

- Lentigo Maligna

## Interventions

- **DRUG:** Picato gel

## Key facts

- **NCT ID:** NCT02723721
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-15
- **Primary completion:** 2020-01-27
- **Final completion:** 2020-01-27
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02723721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02723721, "Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02723721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*